Cognitive Behavioral Therapy-Based Group Counseling (CBTBGC)
December 9, 2019 updated by: Satı Demir, Gazi University
Controlled, Randomized, Cognitive Behavioral Therapy-Based Group Counseling for Nursing Students With Depressive Symptoms
The university environment presents a valuable opportunity to reach the young population of society, which has a high risk of depression, and to provide protective mental-health services.
This study aimed to evaluate the effectiveness of cognitive behavioral therapy-based group counseling focused on the depressive symptoms, anxiety levels, automatic thoughts, and coping ways among undergraduate nursing students with mild to moderate depressive symptoms.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study aimed to evaluate the effectiveness of cognitive behavioral therapy-based group counseling focused on the depressive symptoms, anxiety levels, automatic thoughts, and coping ways among undergraduate nursing students with mild to moderate depressive symptoms.
The study was completed with a total of 63 participants (n=31 for the intervention group and n=32 for the control group) in the 2017-2018 academic year. The effect of the intervention was evaluated with the Beck Depression Inventory, Beck Anxiety Inventory, Automatic Thoughts Questionnaire, and Ways of Coping Questionnaire. The measurements were taken 3 times: pre-test, post-test, and 2-months post-test.
Study Type
Interventional
Enrollment (Actual)
63
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ankara, Turkey, 06500
- Satı Demir
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 25 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Having mild depressive symptoms according to the BDI
- Having moderate depressive symptoms according to the BDI
- Being native speakers of Turkish
- Agreeing to participate in the entire intervention process
Exclusion Criteria:
- Having substance abuse
- Having another psychiatric diagnosis
- Using psychotropic drugs
- Receiving other counseling or therapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive Behavioral Therapy-Based Group Counseling
The CBT-based group counseling provided to the intervention group was carried out as a group intervention with structured sessions in which various techniques and methods of CBT, having mainly educational content, were applied, including an experiential interaction process.
The counseling was performed in a total of six 60- to 90-minute sessions, comprising one session per week for four groups consisting of six to 10 members each.
|
|
|
No Intervention: Control group
No counseling was given to the control group during the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Beck Depression Inventory (BDI)
Time Frame: Change from baseline to 6 weeks (also assessed at 14 weeks post-baseline)
|
It measures the risk level of depression.
It has 21 items.
Each item is scored 0-3 points and the total score ranges from 0-63 (0-9=no; 10-16= mild; 17-20= moderate; 21-26=high; 27 or more points severe depressive symptoms)
|
Change from baseline to 6 weeks (also assessed at 14 weeks post-baseline)
|
|
Beck Anxiety Inventory (BAI)
Time Frame: Change from baseline to 6 weeks (also assessed at 14 weeks post-baseline)
|
This self-assessment scale determines anxiety level.
It consists of 21 items.
Each item is scored 0-3 points and the total score ranges from 0-63.
As the total score increases, the anxiety level increases.
|
Change from baseline to 6 weeks (also assessed at 14 weeks post-baseline)
|
|
Automatic Thoughts Questionnaire (ATQ)
Time Frame: Change from baseline to 6 weeks (also assessed at 14 weeks post-baseline)
|
It measures the thought patterns and negative self-assessments commonly seen in depression.
It consists of 30 items.
Each item is scored 1-5 points and the total score ranges from 30-150 points.
A high score indicates that the frequency of automatic thoughts related to depression is high.
|
Change from baseline to 6 weeks (also assessed at 14 weeks post-baseline)
|
|
Ways of Coping Questionnaire (WCQ)
Time Frame: Change from baseline to 6 weeks (also assessed at 14 weeks post-baseline)
|
It measures the thought patterns and negative self-assessments commonly seen in depression.
It consists of 30 items.
Each item is scored 1-5 points and the total score ranges from 30-150 points.
A high score indicates that the frequency of automatic thoughts related to depression is high.
|
Change from baseline to 6 weeks (also assessed at 14 weeks post-baseline)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Satı Demir, PhD, Gazi University Health Sciences Faculty, Ankara, Turkey
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2017
Primary Completion (Actual)
December 29, 2017
Study Completion (Actual)
February 23, 2018
Study Registration Dates
First Submitted
November 28, 2019
First Submitted That Met QC Criteria
December 9, 2019
First Posted (Actual)
December 10, 2019
Study Record Updates
Last Update Posted (Actual)
December 10, 2019
Last Update Submitted That Met QC Criteria
December 9, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SDemir
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Other researchers will be able to read detailed information such as the research method and results when the research is published.
The "Research Protocol" will be available on the this PRS page.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.